Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.40 |
| ▸ | ICMT | O60725 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.33 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.33 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.32 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20848843 | 0.95 | RORC (0.36) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20848534 | 0.95 | KIF11 (0.37) | KIF11ICMTRXRARXRGRAPGEF3 | |
| SCHEMBL20848920 | 0.94 | KIF11 (0.42) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20848916 | 0.92 | KIF11 (0.41) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20849275 | 0.92 | KIF11 (0.41) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20849565 | 0.90 | KIF11 (0.39) | KIF11ICMTRXRARXRGRAPGEF3 | |
| SCHEMBL20849286 | 0.90 | KIF11 (0.34) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20848570 | 0.90 | KIF11 (0.46) | KIF11RXRARXRGTACR1PTGDR2 | |
| SCHEMBL20848913 | 0.89 | KIF11 (0.38) | KIF11ICMTRXRARXRGTACR1 | |
| SCHEMBL20848842 | 0.89 | RXRA (0.37) | KIF11ICMTRXRARXRGTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-13 | — | — | US | disclosed |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | OCIAD2, OCIAD1, POU2F1 | KIF11 419/4885ICMT 616/4885RXRA 1822/4885 |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD2, OCIAD1, POU2F1 | KIF11 419/4885ICMT 616/4885RXRA 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.